AIP
AZN icon

Ameritas Investment Partners’s AstraZeneca AZN Stock Holding History

Ameritas Investment Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,552
Closed -$1.94M – 3118
2025
Q4 		$1.94M Buy
10,552
+756
+8% +$133K 0.06% 349
2025
Q3 		$1.5M Buy
9,796
+34
+0.3% +$5.15K 0.05% 436
2025
Q2 		$1.36M Buy
9,762
+238
+2% +$33.4K 0.04% 502
2025
Q1 		$1.4M Buy
9,524
+261
+3% +$37.8K 0.05% 478
2024
Q4 		$1.21M Buy
9,263
+502
+6% +$70.3K 0.04% 558
2024
Q3 		$1.37M Buy
8,761
+316
+4% +$51K 0.04% 513
2024
Q2 		$1.32M Hold
8,445
– – 0.05% 503
2024
Q1 		$1.14M Hold
8,445
– – 0.04% 582
2023
Q4 		$1.14M Buy
8,445
+380
+5% +$49.4K 0.04% 564
2023
Q3 		$1.09M Buy
8,065
+1,642
+26% +$224K 0.04% 524
2023
Q2 		$919K Sell
6,423
-34
-0.5% -$5K 0.03% 616
2023
Q1 		$896K Sell
6,457
-36
-0.6% -$4.84K 0.04% 616
2022
Q4 		$878K Sell
6,493
-69
-1% -$8.65K 0.04% 638
2022
Q3 		$719K Buy
6,562
+205
+3% +$26K 0.03% 638
2022
Q2 		$840K Buy
6,357
+106
+2% +$13.9K 0.04% 606
2022
Q1 		$829K Buy
6,251
+6,231
+31,155% +$747K 0.03% 673
2021
Q4 		$2K Hold
20
– – ﹤0.01% 3091
2021
Q3 		$2K Hold
20
– – ﹤0.01% 3073
2021
Q2 		$2K Buy
+20
New +$2.19K ﹤0.01% 3029

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM

Ameritas Investment Partners's AZN Position: Q1 2026 in Review

Ameritas Investment Partners sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 10,552 shares — an estimated $1.94M sold.

Ameritas Investment Partners first reported a position in AZN in Q2 2021 and held it in 19 quarters. The position peaked at $1.94M in Q4 2025. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Ameritas Investment Partners reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Ameritas Investment Partners sold 10,552 AstraZeneca shares in Q1 2026, an estimated $1.94M.
  • Ameritas Investment Partners first reported a position in AstraZeneca in Q2 2021 and held it in 19 quarters.
  • Ameritas Investment Partners's AstraZeneca position peaked at $1.94M in Q4 2025.
  • 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.